loader image
Sunday, February 15, 2026
79.8 F
McAllen
- Advertisement -

Valley Baptist Medical Center-Harlingen Earns Top-Grade In-Patient Safety from The Leapfrog Group

Translate to Spanish or other 102 languages!

Pictured in the center, Manny Vela, CEO of Valley Baptist Medical Center-Harlingen and Valley Baptist Health System. Flanked by UTRGV President Dr. Guy H. Bailey and Dr. Kelly Scrivner Vice President for Institutional Advancement at UTRGV. Photo exclusive by Roberto Hugo Gonzalez

Mega Doctor News

- Advertisement -

HARLINGEN – Valley Baptist Medical Center-Harlingen received an “A” rating in The Leapfrog Group’s Spring 2019 Safety Score, demonstrating the hospital’s commitment to delivering safe, high-quality patient care.

The Leapfrog Group Hospital Safety Score is a rating system designed to give consumers information they can use to make healthcare decisions for themselves or a loved one. The Leapfrog Group assigns A, B, C, D, and F grades to more than 2,600 U.S. hospitals based on their ability to prevent errors, injuries, accidents, and infections.

“Recognition of this sort does not happen by chance,” said Manny Vela, CEO of Valley Baptist Medical Center-Harlingen and Valley Baptist Health System. “It is possible only through the dedication and tireless work of our physicians, nurses, and ancillary staff who treat our patients as though they were family.” 

- Advertisement -

Valley Baptist Medical Center-Harlingen’s “A” safety rating is the fourth-consecutive “A” the hospital has received from The Leapfrog Group, dating back to fall 2017. In addition to receiving The Leapfrog Group’s top safety score, Valley Baptist-Harlingen has also been at the forefront in the effort to provide residents of the Rio Grande Valley with higher levels of care. Valley Baptist-Harlingen was designated the first Comprehensive Stroke Center in the region (2016), as well as the first Level II Trauma Center in the Valley (2018).

To see full grades for Valley Baptist-Harlingen, and to access patient tips for staying safe in the hospital, visit www.hospitalsafetygrade.org.

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

Breakthrough TTFields Technology Gets FDA Approval for Pancreatic Cancer Treatment

Mega Doctor News The U.S. Food and Drug Administration has approved a...

El Paso Researchers Advance New Treatments for Cancer and Heart Disease

Ramadevi Subramani Reddy, Ph.D., remembers the neem tree from her childhood in India — a plant her grandmother used to treat everything from fevers to infections.

STHS Heart Celebrates 30 Years of Cardiovascular Excellence

On January 15, 1996, South Texas Health System (STHS) Heart—then named McAllen Heart Hospital—opened as one of the...

Unexpected Cancer Drug Combo Shows Stronger Results Against Ovarian Tumors

A new study published by Mayo Clinic researchers suggests that ovarian cancer cells quickly activate a survival response after PARP inhibitor treatment, and blocking this early response may make this class of drugs work better.
- Advertisement -
×